Evidence map›Paper›PMID 31713103›Full record

ReviewJournal of cancer education : the official journal of the American Association for Cancer Education2020

Overcoming Barriers: Evidence-Based Strategies to Increase Enrollment of Underrepresented Populations in Cancer Therapeutic Clinical Trials-a Narrative Review.

Iris Vuong, Joshua Wright, Margaret B Nolan, Amanda Eggen, Erin Bailey, Rick Strickland, Anne Traynor, Tracy Downs

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of cancer education : the official journal of the American Association for Cancer Education, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. How to optimize and evaluate diversity in gynecologic cancer clinical trials: statements from the GCIG Barcelona Meeting.International journal of gynecological cancer : official journal of the International Gynecological Cancer Society · 2024
    Article
  12. Impact of Clinical Trial Design on Recruitment of Racial and Ethnic Minorities.Journal of cancer education : the official journal of the American Association for Cancer Education · 2024
    Article
  13. Diversity, Equity, and Inclusion in Multiple Myeloma: A Call to Action.Journal of the advanced practitioner in oncology · 2024
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Interventions to improve access to clinical trials in urologic oncology.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Iris VuongCarbone Cancer Center, Cancer Health Disparities Initiative, School of Medicine and Public Health, University of Wisconsin - Madison, 610 Walnut Street, 370 WARF, Madison, WI, 53726, USA.
Joshua WrightCarbone Cancer Center, Cancer Health Disparities Initiative, School of Medicine and Public Health, University of Wisconsin - Madison, 610 Walnut Street, 370 WARF, Madison, WI, 53726, USA. jawright@wisc.edu.ORCID 0000-0002-4969-7502
Margaret B NolanDepartment of Population Health Sciences, School of Medicine and Public Health, University of Wisconsin - Madison, 610 Walnut Street, 1032 WARF, Madison, WI, 53726, USA.
Amanda EggenCarbone Cancer Center, Cancer Health Disparities Initiative, School of Medicine and Public Health, University of Wisconsin - Madison, 610 Walnut Street, 370 WARF, Madison, WI, 53726, USA.
Erin BaileyCarbone Cancer Center, Cancer Health Disparities Initiative, School of Medicine and Public Health, University of Wisconsin - Madison, 610 Walnut Street, 370 WARF, Madison, WI, 53726, USA.
Rick StricklandCarbone Cancer Center, Cancer Health Disparities Initiative, School of Medicine and Public Health, University of Wisconsin - Madison, 610 Walnut Street, 370 WARF, Madison, WI, 53726, USA.
Anne TraynorDepartment of Medicine, School of Medicine and Public Health, University of Wisconsin - Madison, 1111 Highland Avenue, 3103 WI Institute Medical Research, Madison, WI, 53705, USA.
Tracy DownsDepartment of Urology, School of Medicine and Public Health, University of Wisconsin - Madison, 8007 Excelsior Drive, 3223 UW Medical Foundation, Madison, WI, 53717, USA.
University of Wisconsin–Madison · US

Funding

UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI Christian Capitini · 1985 to 2026
$142.6M
NCI NIH HHS P30 CA014520
6 · The paper itself

Abstract

Disparities in cancer incidence and mortality rates among racial and ethnic minorities (African Americans, Asian Americans, Pacific Islanders, American Indians, and Latinos/Hispanic Americans) in the USA are well documented. Enrollment of underrepresented populations in cancer therapeutic clinical trials, however, is very low. This is true despite federal mandates to ensure accrual rates adequate for analyses and the evidence that the effectiveness of specific therapies and medications varies across ethnic and racial groups. Consequently, cancer clinical decision-making is based on research studies where the majority of research participants are white males, despite the disproportionate cancer burden in racial and ethnic minority groups. To date, there have been multiple reviews detailing the barriers to enrollment for these populations in cancer clinical trials, but a notable lack of research on possible strategies to overcome them. The aim of this narrative review is to summarize the current evidence for effective approaches to increase enrollment of underrepresented minorities in cancer therapeutic clinical trials. These approaches include (1) cultural and linguistic adaptations of marketing materials, (2) the use of patient navigators, and (3) building ongoing community partnerships. The majority of studies reviewed employ multiple improvement strategies simultaneously. Identifying effective approaches to increase enrollment of underrepresented populations in cancer clinical trials is a critical step in reducing persistent disparities in cancer incidence and mortality among racial and ethnic populations.

Indexed as

Patient SelectionClinical Trials as TopicEthnicityHumansMinority GroupsNeoplasmsBarriersEnrollment into clinical trialsStrategiesUnderrepresented populations

Identifiers

PMID31713103
OpenAlexW2989004662

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.